Prime Therapeutics’ Post

View organization page for Prime Therapeutics, graphic

56,654 followers

85% of individuals who newly started glucagon-like peptide-1 (GLP-1) agonist drugs for weight loss were no longer taking the drug after 2 years. Read more from our recent GLP-1 real-world analysis here: https://bit.ly/3WdWkOC

To view or add a comment, sign in

Explore topics